Qiagen (NYSE: QGEN) reported Q1 EPS of $0.27, $0.01 better than the analyst estimate of $0.26. Revenue for the quarter came in at $348.7 million versus the consensus estimate of $350.65 million.

• New $100 million share repurchase program planned
• QIAGEN reaffirms 2019 outlook for growth in net sales and adjusted EPS (at CER)

For earnings history and earnings-related data on Qiagen (QGEN) click here.